A Efficacy and Safety Study of Intramuscular Injection of Human Placenta-Derived Cells (PDA-002) in Subjects With Diabetic Peripheral Neuropathy
Clinical trial NCT02552277 · COMPLETED
Trial details
- NCT number
- NCT02552277
- Sponsor
- Celularity Incorporated
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-10-27
- Primary completion
- 2017-03-07
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.